Back in medical school, I remember a lecture on celiac disease. The professor declared, with great enthusiasm, “Celiac disease is the one autoimmune condition we can cure—with a gluten-free diet!” As a first-year student, I thought that was incredible. A chronic disease, fixed by a dietary change? It seemed so simple.

Years later, after treating patients, meeting friends, and hearing from family members with celiac disease, I realize just how wrong that professor was. A gluten-free diet isn’t a cure—it’s a complex, lifelong burden. The financial cost alone is substantial; gluten-free products are significantly more expensive and often inaccessible. But the hidden costs are even greater: the anxiety of accidental exposure, the isolation from social events, the difficulty trusting restaurants or even friends’ kitchens.

Unfortunately, the medical system often overlooks these challenges. Primary care physicians and gastroenterologists are pressed for time, navigating a sea of checkboxes just to get through the day. When a disease has a “dietary treatment,” it’s too easy for the deeper impact on daily life to go unnoticed.

So when we first began testing ads for celiac trials, I expected moderate interest at best. Instead, we were overwhelmed. Every day, more and more people reached out—eager to join. It quickly became clear how deeply motivated the celiac community is to find real treatment options.

Participants come in with the long view. Many are doing this not just for themselves, but for their children, their friends, their community. They’re volunteering their time, undergoing invasive procedures, and even consuming gluten—not in the form of a bagel, but often as a pill or powder—all in service of moving the science forward.

They do this knowing they may not benefit personally in the short term. They do it because they believe in a future where celiac disease is more than managed—it’s truly treated.

And that’s what I’ve learned: the celiac community isn’t just waiting for a cure. They’re actively building the path to it.